Cantor Fitzgerald’s virtual panel on “Emerging Targets in Development for Inflammatory Bowel Disease (IBD)”

  • April 27, 2021 - April 27, 2021
  • Virtual panel discussion

We are delighted to participate in a virtual panel discussion on “Emerging Targets in Development for Inflammatory Bowel Disease (IBD)”, which will be hosted by Cantor Fitzgerald Equity Research on April 27 at 10:00AM ET.
Invited speakers from Biomica: Dr. Elran Haber , CEO and Dr. Shiri Meshner, VP R&D.

Back to all News

Highlighted News About Biomica

Oct 21, 2024

BIO-Europe 2024

Biomica will be attending Bio Europe conference, and we’re looking forward to connecting with industry leaders and innovators. Our CEO, Dr. Elran Haber, and VP of Business Development, Mel Larrosa, will be available for meetings.

Jul 1, 2024

9th Microbiome Movement – Drug Development Summit

Dr. Elran Haber, CEO of Biomica, will be participating as a panelist at the 9th Microbiome Movement – Drug Development Summit. On July 12th at 9:30 am ET, Dr. Haber will engage in the panel discussion “Defining Innovative Clinical Strategies Conserving Spend.” This discussion will explore adaptive trial methodologies, strategic partnerships, and criteria for attracting […]